help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beaujean, D.
Right arrow Articles by Vaudry, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beaujean, D.
Right arrow Articles by Vaudry, H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Endocrinology Vol. 143, No. 5 1950-1963
Copyright © 2002 by The Endocrine Society


NEUROENDOCRINOLOGY

Neuropeptide Y Inhibits the Biosynthesis of Sulfated Neurosteroids in the Hypothalamus through Activation of Y1 Receptors

Delphine Beaujean1, Jean-Luc Do-Rego, Ludovic Galas, Ayikoe G. Mensah-Nyagan, Robert Fredriksson, Dan Larhammar, Alain Fournier, Van Luu-The, Georges Pelletier and Hubert Vaudry2

European Institute for Peptide Research (IFRMP 23), Laboratory of Cellular and Molecular Neuroendocrinology, INSERM U-413, UA Centre National de la Recherche Scientifique, University of Rouen (D.B., J.-L.D.-R., L.G., A.G.M.-N., H.V.), 76821 Mont-Saint-Aignan, France; Department of Neuroscience, Unit of Pharmacology, Uppsala University (R.F., D.L.), 75124 Uppsala, Sweden; Institut National de la Recherche Scientifique-Institut Armand Frappier, University of Quebec (A.F.), Pointe-Claire, Montréal, Canada H9R 1G6; and Medical Research Council Group in Molecular Endocrinology, Laval University Medical Center (V.L.-T., G.P.), Québec, Canada G1V 4G2

Address all correspondence and requests for reprints to: Dr. Hubert Vaudry, European Institute for Peptide Research (IFRMP 23), Laboratory of Cellular and Molecular Neuroendocrinology, INSERM U-413, UA Centre National de la Recherche Scientifique, University of Rouen, 76821 Mont Saint Aignan, France. E-mail: . hubert.vaudry{at}univ-rouen.fr

We have recently shown that hydroxysteroid sulfotransferase (HST), the enzyme responsible for the biosynthesis of pregnenolone sulfate ({Delta}5PS) and dehydroepiandrosterone sulfate (DHEAS), is expressed in neurons located in the anterior preoptic area and the dorsal magnocellular nucleus of the frog diencephalon. As these two nuclei are richly innervated by NPY-immunoreactive fibers, we investigated the possible implication of NPY in the control of {Delta}5PS and DHEAS biosynthesis. Double labeling of frog brain sections revealed that 42% of the HST-immunoreactive perikarya in the diencephalon were contacted by NPY-containing fibers. In situ hybridization studies showed that Y1 and Y5 receptor mRNAs are expressed in the anterior preoptic area and the dorsal magnocellular nucleus. Pulse-chase experiments with 35S-labeled 3'-phosphoadenosine 5'-phosphosulfate as a sulfate donor demonstrated that frog NPY (fNPY) inhibited the conversion of [3H]{Delta}5P and [3H]dehydroepiandrosterone ([3H]DHEA) into [3H,35S]{Delta}5PS and [3H,35S]DHEAS by diencephalic explants. The inhibitory effect of fNPY on {Delta}5PS and DHEAS formation was mimicked by (pPYY) and [Leu31,Pro34]pNPY, which is an agonist for non-Y2 receptors in mammals, and was completely suppressed by the Y1 receptor antagonist BIBP3226. Conversely, the Y2 receptor agonist pNPY-(13–36) and the Y5 receptor agonist [D-Trp32]pNPY did not significantly modify the biosynthesis of [3H,35S]{Delta}5PS and [3H,35S]DHEAS. The present study provides the first evidence for the innervation of neurosteroid-producing neurons by NPY fibers. Our data also demonstrate that NPY, acting via Y1 receptors, exerts an inhibitory effect on the biosynthesis of sulfated neurosteroids.




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
M. Schumacher, R. Guennoun, A. Ghoumari, C. Massaad, F. Robert, M. El-Etr, Y. Akwa, K. Rajkowski, and E.-E. Baulieu
Novel Perspectives for Progesterone in Hormone Replacement Therapy, with Special Reference to the Nervous System
Endocr. Rev., June 1, 2007; 28(4): 387 - 439.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J.-L. Do-Rego, S. Acharjee, J. Y. Seong, L. Galas, D. Alexandre, P. Bizet, A. Burlet, H. B. Kwon, V. Luu-The, G. Pelletier, et al.
Vasotocin and mesotocin stimulate the biosynthesis of neurosteroids in the frog brain.
J. Neurosci., June 21, 2006; 26(25): 6749 - 6760.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
I. Charalampopoulos, E. Dermitzaki, L. Vardouli, C. Tsatsanis, C. Stournaras, A. N. Margioris, and A. Gravanis
Dehydroepiandrosterone Sulfate and Allopregnanolone Directly Stimulate Catecholamine Production via Induction of Tyrosine Hydroxylase and Secretion by Affecting Actin Polymerization
Endocrinology, August 1, 2005; 146(8): 3309 - 3318.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. Porter, M. Van Vrancken, C. Corll, H. Thompson, and F. Svec
The influence of dehydroepiandrosterone and 8-OH-DPAT on the caloric intake and hypothalamic neurotransmitters of lean and obese Zucker rats
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2005; 288(4): R928 - R935.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society